As shown in Figure 3C, knocking down CLK4 enhanced 15N‐purine intermediates, whereas WT‐CLK4 but not inactive CLK4‐K189R mutant decreased IMP, AMP, and guanosine monophosphate (GMP) in ESCC cells. The gene discussed is CLK4; the disease is esophageal squamous cell carcinoma.